Fever prophylaxis can reduce vaccine responses: A caution.

Area of Science:

• Pediatrics
• Immunology
• Pharmacology

Background:

• Antipyretic/analgesic drugs are sometimes given prophylactically to infants during immunization to manage fever and irritability.
• Concerns exist regarding the potential impact of prophylactic medication on infant vaccine responses.

Purpose of the Study:

• To evaluate the effect of prophylactic antipyretic/analgesic administration on infant immune responses to vaccines.
• To determine optimal timing for administering these medications to minimize interference with vaccine efficacy.

Main Methods:

• Review of recent studies examining the impact of prophylactic and delayed administration of antipyretic/analgesic drugs on infant vaccine responses.
• Analysis of immune response data in infants receiving different medication timing regimens.

Main Results:

• Prophylactic administration of antipyretic/analgesic drugs at the time of immunization and repeated 6 and 12 hours later was shown to reduce immune responses to certain infant vaccines.
• Administering treatment 6 hours or more after immunization did not affect vaccine responses.

Conclusions:

• Judicious use of prophylactic antipyretic/analgesic drugs is warranted due to potential reduction in infant vaccine effectiveness.
• Delayed administration (≥6 hours post-immunization) is a viable strategy to mitigate fever/irritability without compromising vaccine responses and reducing drug exposure.